Robert Hopfner's most recent trade in Rallybio Corp was a trade of 28,500 Option (Right to Buy) done . Disclosure was reported to the exchange on May 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rallybio Corp | Robert Hopfner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 28,500 | 28,500 | - | - | Option (Right to Buy) | |
| Rallybio Corp | Robert Hopfner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 73,571 | 73,571 | - | - | Option (Right to Buy) | |
| Inozyme Pharma Inc | Robert Hopfner | Director | 18 Jun 2024 | 28,000 | 28,000 | - | - | Stock Option (right to buy) | ||
| Rallybio Corp | Robert Hopfner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 16,500 | 16,500 | - | - | Option (Right to Buy) | |
| Inozyme Pharma Inc | Robert Hopfner | Director | 01 Aug 2023 | 714,285 | 1,571,741 | - | 4.8 | 3,428,568 | Common Stock | |
| Inozyme Pharma Inc | Robert Hopfner | Director | 01 Aug 2023 | 119,048 | 2,923,110 | - | 4.8 | 571,430 | Common Stock | |
| Inozyme Pharma Inc | Robert Hopfner | Director | 13 Jun 2023 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | ||
| Inozyme Pharma Inc | Robert Hopfner | Director | 11 May 2023 | 228,702 | 3,661,518 | - | 6.3 | 1,429,388 | Common Stock | |
| Inozyme Pharma Inc | Robert Hopfner | Director | 11 May 2023 | 219,230 | 3,432,816 | - | 6.5 | 1,420,610 | Common Stock | |
| Inozyme Pharma Inc | Robert Hopfner | Director | 29 Mar 2023 | 344,592 | 3,213,586 | - | 4.5 | 1,563,724 | Common Stock | |
| Inozyme Pharma Inc | Robert Hopfner | Director | 27 Mar 2023 | 156,766 | 2,868,994 | - | 4.2 | 652,335 | Common Stock | |
| Inozyme Pharma Inc | Robert Hopfner | Director | 27 Mar 2023 | 51,074 | 2,712,228 | - | 3.7 | 188,729 | Common Stock | |
| Inozyme Pharma Inc | Robert Hopfner | Director | 10 Jun 2022 | 9,367 | 9,367 | - | - | Stock Option (Right to Buy) | ||
| Rallybio Corp | Robert Hopfner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 13,440 | 13,440 | - | - | Option (Right to Buy) | |
| Inozyme Pharma Inc | Robert Hopfner | Director | 19 Apr 2022 | 1,070,000 | 2,661,154 | - | 3.7 | 3,948,300 | Common Stock | |
| Rallybio Corp | Robert Hopfner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 6,242 | 6,242 | - | - | Option (Right to Buy) | |
| Rallybio Corp | Robert Hopfner | Director | Other type of transaction at price $ 0.00 per share. | 28 Jul 2021 | 10,789,193 | 0 | - | - | Series B Preferred Units | |
| Rallybio Corp | Robert Hopfner | Director | Other type of transaction at price $ 0.00 per share. | 28 Jul 2021 | 1,694,388 | 1,694,388 | - | - | Common Stock | |
| Rallybio Corp | Robert Hopfner | Director | Purchase of securities on an exchange or from another person at price $ 13.00 per share. | 28 Jul 2021 | 576,923 | 2,267,411 | - | 13 | 7,499,999 | Common Stock |
| Rallybio Corp | Robert Hopfner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2021 | 13,440 | 13,440 | - | - | Option (Right to Buy) | |
| Inozyme Pharma Inc | Robert Hopfner | Director | 23 Jun 2021 | 9,367 | 9,367 | - | - | Stock Option (right to buy) | ||
| Vaxcyte Inc | Robert Hopfner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 28.75 per share. | 08 Feb 2021 | 93,740 | 1,483,576 | - | 28.8 | 2,695,025 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 28.07 per share. | 08 Feb 2021 | 88,756 | 1,577,316 | - | 28.1 | 2,491,381 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 25.64 per share. | 08 Feb 2021 | 50,874 | 1,733,242 | - | 25.6 | 1,304,409 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 27.12 per share. | 08 Feb 2021 | 38,248 | 1,666,072 | - | 27.1 | 1,037,286 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 25.75 per share. | 08 Feb 2021 | 37,271 | 1,446,305 | - | 25.7 | 959,728 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 26.06 per share. | 08 Feb 2021 | 28,922 | 1,704,320 | - | 26.1 | 753,707 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 26.78 per share. | 08 Feb 2021 | 26,688 | 1,419,617 | - | 26.8 | 714,705 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 27.64 per share. | 08 Feb 2021 | 7,567 | 1,412,050 | - | 27.6 | 209,152 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 28.66 per share. | 08 Feb 2021 | 6,632 | 1,405,418 | - | 28.7 | 190,073 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 25.13 per share. | 02 Feb 2021 | 14,234 | 1,786,884 | - | 25.1 | 357,700 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 25.06 per share. | 02 Feb 2021 | 2,768 | 1,784,116 | - | 25.1 | 69,366 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 25.07 per share. | 28 Jan 2021 | 2,000 | 1,801,118 | - | 25.1 | 50,140 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 25.61 per share. | 25 Jan 2021 | 19,511 | 1,838,861 | - | 25.6 | 499,677 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 25.23 per share. | 25 Jan 2021 | 16,769 | 1,806,631 | - | 25.2 | 423,082 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 26.07 per share. | 25 Jan 2021 | 15,461 | 1,823,400 | - | 26.1 | 403,068 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 25.30 per share. | 25 Jan 2021 | 2,140 | 1,803,118 | - | 25.3 | 54,142 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 26.13 per share. | 25 Jan 2021 | 1,373 | 1,805,258 | - | 26.1 | 35,876 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 25.35 per share. | 20 Jan 2021 | 19,046 | 1,869,855 | - | 25.3 | 482,816 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 25.16 per share. | 20 Jan 2021 | 11,383 | 1,858,372 | - | 25.2 | 286,396 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 25.11 per share. | 20 Jan 2021 | 100 | 1,869,755 | - | 25.1 | 2,511 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 25.55 per share. | 14 Jan 2021 | 42,516 | 1,895,901 | - | 25.6 | 1,086,284 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 25.74 per share. | 14 Jan 2021 | 22,869 | 1,942,225 | - | 25.7 | 588,648 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 25.88 per share. | 14 Jan 2021 | 14,918 | 1,965,094 | - | 25.9 | 386,078 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 26.05 per share. | 14 Jan 2021 | 7,000 | 1,888,901 | - | 26.1 | 182,350 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 26.05 per share. | 14 Jan 2021 | 3,808 | 1,938,417 | - | 26.0 | 99,198 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 25.90 per share. | 11 Jan 2021 | 26,010 | 1,983,112 | - | 25.9 | 673,659 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 26.69 per share. | 11 Jan 2021 | 24,980 | 2,039,895 | - | 26.7 | 666,716 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 26.35 per share. | 11 Jan 2021 | 17,666 | 2,010,023 | - | 26.3 | 465,499 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 25.42 per share. | 11 Jan 2021 | 12,480 | 2,064,875 | - | 25.4 | 317,242 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 27.02 per share. | 11 Jan 2021 | 12,206 | 2,027,689 | - | 27.0 | 329,806 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 26.34 per share. | 11 Jan 2021 | 3,100 | 1,980,012 | - | 26.3 | 81,654 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 27.05 per share. | 11 Jan 2021 | 901 | 2,009,122 | - | 27.0 | 24,372 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 29.24 per share. | 06 Jan 2021 | 34,913 | 2,188,054 | - | 29.2 | 1,020,856 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 26.43 per share. | 06 Jan 2021 | 31,468 | 2,086,499 | - | 26.4 | 831,699 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 27.75 per share. | 06 Jan 2021 | 24,524 | 2,141,023 | - | 27.8 | 680,541 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 28.80 per share. | 06 Jan 2021 | 22,587 | 2,118,436 | - | 28.8 | 650,506 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 29.99 per share. | 06 Jan 2021 | 22,507 | 2,165,547 | - | 30.0 | 674,985 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 27.08 per share. | 06 Jan 2021 | 8,944 | 2,077,555 | - | 27.1 | 242,204 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 29.51 per share. | 06 Jan 2021 | 469 | 2,117,967 | - | 29.5 | 13,840 | Common Stock |
| Vaxcyte Inc | Robert Hopfner | Director | Sale of securities on an exchange or to another person at price $ 28.23 per share. | 06 Jan 2021 | 200 | 2,077,355 | - | 28.2 | 5,646 | Common Stock |